Call Options Transactions Made in Q3 2023 in Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS) during Q3 2023. The information is specifically focused on institutions that hold call options of Aclaris Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Great Point Partners LLC
Greenwich, CT |
BUY
|
CALL |
700KNew |
$4.59M - $7.66M
|
700K
$2.67M
|
|
|
Nov 14, 2023
Q3 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
443K+ 4385.15% |
$2.91M - $4.85M
|
453K
$1.73M
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
272K+ 187.78% |
$1.78M - $2.98M
|
417K
$1.59M
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
118K+ 109.0% |
$771K - $1.29M
|
225K
$861K
|
|
|
Nov 14, 2023
Q3 2023
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
CALL |
73.2KNew |
$480K - $802K
|
73.2K
$280K
|
|
|
Nov 14, 2023
Q3 2023
|
Ubs Oconnor LLC
Chicago, IL |
BUY
|
CALL |
70KNew |
$459K - $767K
|
70K
$267K
|
|
|
Nov 14, 2023
Q3 2023
|
Nomura Holdings Inc
Tokyo, M0 |
BUY
|
CALL |
45.3KNew |
$297K - $496K
|
45.3K
$173K
|
|
|
Nov 14, 2023
Q3 2023
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
3.64KNew |
$23.9K - $39.8K
|
3.64K
$13.9K
|
|
|
Oct 27, 2023
Q3 2023
|
Belvedere Trading LLC
|
SELL
|
CALL |
-12.6K- 84.0% |
$82.7K - $138K
|
2.4K
$9.17K
|
|
|
Nov 14, 2023
Q3 2023
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
CALL |
-29.8K- 54.08% |
$195K - $326K
|
25.3K
$96.6K
|
|
|
Nov 13, 2023
Q3 2023
|
Silverarc Capital Management, LLC
|
SELL
|
CALL |
-452K- 69.45% |
$2.97M - $4.95M
|
199K
$760K
|